Cornish-Bowden, A. (2004). Fundamentals of Enzyme Kinetics. Portland Press.
Dunaway-Mariano, D. (2008). Enzyme Function Discovery. Structure, Vol.16 Issue 11, 1599-1600.
Fernandez, P., Canada, J.F., Jiminez-Barbero, J., & Martin-Lomas, M. (1995). Substrate Specificity of Small-Intestinal Lactase: Study of the Steric effects and Hydrogen Bonds involved in Enzyme-Substrate Interaction. Carbohydrate Research Volume 271, Issue 1, 31-42.
Naim, Y.H., Sterchi, E., & Lentze, M. (1987). Biosynthesis and Maturation of Lactase-Phlorizin Hydrolase in the Human Small Intestinal Epithelial Cells. Biochemical Journal Vol. 241 No. 2, 427-434.
Sallee, J., & Clapper, A. (2007). The Effects of Temperature and Chelating Agents on Catechol Oxidation. Andrew's Online Journal.
Schneider, R.E., Corona, E., Rosales, F., Schneider, E.F., Rodriguez, O., & Pineda, O. (1990). Effect of Temperature on the Lactose Hydrolytic Capacity of a Lactase derived from Kluyveromyces Lactis. American Journal of Clinical Nutrition Vol. 51 No. 2, 197-201.
Wilson, J. (2005). Milk Intolerance: Lactose Intolerance and Cow's Milk Protein Allergy. Newborn and Infant Nursing Reviews, Vol. 5 Issue 4, 203-207.
1) Burton Goldberg, 'Alternative Medicine', Second Edition, 2002, Berkley Books
2) UMMC, 'Bromelain: Overview', Accessed Mar 17th 2010, available at, http://www.umm.edu/altmed/articles/bromelain-000289.htm
3) Andres Illanes, 'Enzyme Biocatalysis: Principles and Applications', Springer Publications, 2008.
4) EIR, 'Antifungal Treatment', Accessed Mar 17th 2010, available at, http://www.ei-resource.org/treatment-options/treatment-information/antifungal-treatment/
5) Nemours Foundation, 'Lactose Intolerance', Accessed Mar 17th 2010, available at, http://kidshealth.org/teen/food_fitness/nutrition/lactose_intolerance.html
6) ERG, 'Enzymes: The Difference Between Plant and Animal', Accessed Mar 17th 2010, available at, http://www.enzymeresearchgroup.net/docs/Animal_Enzymes_vs_Plant_Enzymes.pdf
Balloon diameter is directly related to the temperature. As increase in temperature causes expansion of gas molecules, therefore, the volume and thus the diameter of balloon also increases (Seager & Slabaugh 2010).
7. Do you expect more enzyme activity if the substrate concentration is increased or decreased? Draw a graph to illustrate this relationship.
With an increase in substrate concentration, enzyme activity will significantly increase at initial values. However, as the active sites of enzymes get occupied by substrate molecules, the rate of reaction will not remain dependent prominently on the amount of substrate as then substrate molecules have to queue
Cole S. L & Vassar, R. (2007). The Alzheimer's disease ?-secretase enzyme, BACE1. Molecular
Neurodegeneration 2007, 2:22 doi:10.1186/1750-1326-2-22
Dominguez D, et al. Phenotypic and biochemical analyses of BACE1- and BACE2-
deficient mice. J Biol Chem. 2005;280:30797 -- 30806
Hong-Qi, Y., Zhi-Kun, S. & Sheng-Di. C. (2012). Current advances in the treatment of Alzheimer's disease: focused on considerations targeting A? And tau. Translational Neurodegeneration 2012, 1:21 doi:10.1186/2047-9158-1-21
Hu X, et al. Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB
J. 2008;22:2970 -- 2980.
Lazarov O, et al. Environmental enrichment reduces A? levels and amyloid deposition in transgenic mice. Cell. 2005;120:701 -- 713.
Lu, Q. et al. (2012). L655,240, acting as a competitive BACE1 inhibitor, efficiently decreases ?-
amyloid peptide production in HEK293-APPswe cells. Acta Pharmacologica Sinica
(2012) 33: 1459 -- 1468; doi: 10.1038/aps.2012.74
Luo Y, et al. Mice deficient in BACE1, the Alzheimer's ?-secretase, have normal phenotype and abolished ?-amyloid generation. Nat Neurosci. 2001;4:231 -- 232.
McConlogue L, et al. Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice. J Biol Chem. 2007;282:26326 -- 26334.
McGowan E, et al. A?42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005; 47:191 -- 199
Nishitomi K, et al. BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice. J Neurochem. 2006;99:1555 -- 1563.
Ring S, et al. The secreted ?-amyloid precursor protein ectodomain APPs? is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-
deficient mice. J Neurosci. 2007;27:7817 -- 7826.
Roberds SL, et al. BACE knockout mice are healthy despite lacking the primary ?-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol
Genet. 2001;10:1317 -- 1324.
Vassar R. & Kandalepas, P.C. (2010).The ?-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease. Alzheimer's Res. Ther. 2011; 3(3):20-36